| Product Name | MF | CAS | Details |
|---|
| GABA-AT-IN-1 | C23H18N2O6 | 242148-96-5 | Details |
| Antibacterial agent 72 | C19H21BrN4S | 2412500-67-3 | Details |
| Estrogen receptor β antagonist 2 | C23H26N2O6 | 2580941-14-4 | Details |
| SARS-CoV-2 nsp13-IN-2 | C20H18N6OS2 | 522660-61-3 | Details |
| PD-1/PD-L1-IN 5 | C22H18N4O3S | 2170209-51-3 | Details |
| Cdc7-IN-10 | C20H22F2N4O2S | 2649409-20-9 | Details |
| HBV-IN-9 | C22H24FN7O | 2170998-69-1 | Details |
| Analgesic agent-1 | C23H19FN4OS | 2230243-92-0 | Details |
| CSF1R-IN-7 | C22H22N6O3 | 2738328-56-6 | Details |
| Antiviral agent 14 | C24H26O7 | 2755814-80-1 | Details |
| Bcl-2/Mcl-1-IN-1 | C28H23NO3 | 2673361-08-3 | Details |
| AR524 | C26H30N2O3 | 2568148-31-0 | Details |
| IDO-IN-14 | C23H23ClN4O2 | 2568302-02-1 | Details |
| Antileishmanial agent-10 | C25H41NO2S | 2397639-33-5 | Details |
| TLR9-IN-1 | C23H31N7O | 2226366-86-3 | Details |
| ATR-IN-10 | C27H24N4O | 2713577-93-4 | Details |
| VEGFR-2-IN-25 | C24H22N6O2 | 2439096-02-1 | Details |
| TRK-IN-21 | C22H22F2N6O | 2429985-55-5 | Details |
| Human enteropeptidase-IN-1 | C20H18N4O7 | 1802891-23-1 | Details |
| Topoisomerase IIα-IN-1 | C22H20N4O5 | 2407521-87-1 | Details |
| Antitrypanosomal agent 4 | C18H14ClN3O5S | 2456427-48-6 | Details |
| CSF1R-IN-6 | C20H18N8O3 | 2716184-87-9 | Details |
| Antifungal agent 33 | C21H14ClN5O3 | 2445277-57-4 | Details |
| SARS-CoV-2 nsp13-IN-6 | C21H19N5O3S | 951588-85-5 | Details |
| Pparδ agonist 7 | C25H25NO5 | 2340432-40-6 | Details |
| PI3KC2α-IN-1 | C19H16N6O2S2 | 2397679-87-5 | Details |
| mGluR2 modulator 1 | C21H20F3N3O3 | 2671063-84-4 | Details |
| α-Glucosidase-IN-11 | C23H20N2O6 | 2411744-76-6 | Details |
| ALK5-IN-28 | C25H27N7 | 2785430-84-2 | Details |
| P-CAB agent 1 | C26H23FN4O | 2374139-68-9 | Details |
| Tubulin inhibitor 13 | 2883436-66-4 | Details |
| Tubulin polymerization-IN-9 | C19H19NO5Se | 2485020-93-5 | Details |
| HSR1304 | C24H21ClN2O3 | 2763363-08-0 | Details |
| TLR7/8 agonist 6 | C24H27N5O2 | 2115702-83-3 | Details |
| NIC-0102 | C21H25BF2N2O4 | 2806031-94-5 | Details |
| PIM1-IN-6 | C21H18N6O4 | 2439168-69-9 | Details |
| Antileishmanial agent-12 | C25H21N3O4 | 2482764-71-4 | Details |
| CEP-9722 | C24H26N4O3 | 916574-83-9 | Details |
| ANKRD22-IN-1 | C22H30N4O4 | 1107710-62-2 | Details |
| TNK2-IN-1 | C23H24N6O2 | 2574456-10-1 | Details |
| ALPK1-IN-2 | C20H18F2N4O2S | 2765633-68-7 | Details |
| Dual AChE-MAO B-IN-2 | C26H25NO4 | 1801157-64-1 | Details |
| Hsp90-IN-15 | C23H27F3N4 | 2252283-32-0 | Details |
| TRPC5 modulator-1 | C23H27FN2O4 | 1877343-90-2 | Details |
| AMG9678 | C20H18F6N2O | 1159997-27-9 | Details |
| CHNQD-01255 | C23H29NO6 | 2756173-91-6 | Details |
| IDO-IN-16 | C22H21F3N4O | 2663591-36-2 | Details |
| AMG8788 | C23H18F4N2O | 1159996-43-6 | Details |
| HF50731 | C26H46N4 | 2484771-19-7 | Details |
| NW 1028 | C19H21N5O4S | 2749599-78-6 | Details |
| PXYD3 | C25H21NO5 | 2680554-46-3 | Details |
| DprE1-IN-4 | C20H21N3O5S | 2419160-96-4 | Details |
| RBP4 ligand-1 | C18H18ClF3N4O2 | 260553-24-0 | Details |
| Cdc7-IN-11 | C20H22F2N4O2S | 2649409-19-6 | Details |
| μ opioid receptor agonist 1 | C26H38N4O | 2667632-83-7 | Details |
| Tubulin polymerization-IN-25 | C24H18N2O3S | 2490538-46-8 | Details |
| PXYD4 | C25H21NO5 | 2712534-78-4 | Details |
| JAK3/BTK-IN-5 | C19H22ClN7O2 | 2673196-75-1 | Details |
| S-777469 | C23H27FN2O4 | 885496-53-7 | Details |
| Cap-dependent endonuclease-IN-25 | C25H25N3O3 | 2415788-71-3 | Details |
| Antifungal agent 24 | C24H18F2N4O | 2566522-60-7 | Details |
| HBV-IN-13 | C22H25NO7 | 2724228-72-0 | Details |
| γ-Secretase modulator 13 | C22H23FN6S | 1353570-40-7 | Details |
| HPK1-IN-30 | C25H23FN6 | 2700292-56-2 | Details |
| α7 nAchR-JAK2-STAT3 agonist 1 | C25H30O6 | 2108714-20-9 | Details |
| GPVI antagonist 2 | C24H27N3O4 | 880399-00-8 | Details |
| Sirt1/2-IN-1 | C22H13ClN2OS2 | 2402779-21-7 | Details |
| AChE/BChE-IN-2 | C23H25N3O5 | 2761991-42-6 | Details |
| Antimalarial agent 11 | C25H25F2NO3 | 1214454-56-4 | Details |
| JAK3/BTK-IN-3 | C22H28N8O | 2674036-98-5 | Details |
| Neuroinflammatory-IN-2 | C25H27FN2O3 | 2361384-14-5 | Details |
| J-1063 | C24H19N5OS | 2374772-46-8 | Details |
| (S)-MALT1-IN-5 | C17H17ClF2N6O3 | 2434602-25-0 | Details |
| Influenza virus-IN-4 | C23H31FN2O4 | 2133818-85-4 | Details |
| PHD2/HDACs-IN-1 | C18H19N9O4 | 2339867-53-5 | Details |
| Topoisomerase IIα-IN-2 | C22H20N4O5 | 2407521-90-6 | Details |
| CDK9-IN-14 | C21H23F2N3O4 | 2650640-17-6 | Details |
| NRX-2663 | C20H13F3N2O5 | 2763260-34-8 | Details |
| GP3269 | C23H21FN4O3 | 186393-42-0 | Details |
| Factor B-IN-3 | C24H29N3O4 | 2760669-74-5 | Details |
| MALT1-IN-5 | C17H17ClF2N6O3 | 2434602-73-8 | Details |
| COX-2-IN-21 | C21H22N6O4 | 2519631-11-7 | Details |
| Retezorogant | C23H33ClN2O3 | 1950570-48-5 | Details |
| CSF1R-IN-10 | C25H22N4O3 | 2765301-88-8 | Details |
| CDK4/6-IN-9 | C22H23FN8 | 2688098-02-2 | Details |
| HBV-IN-11 | C21H24ClNO6 | 2226178-41-0 | Details |
| FWM-4 | C24H18N4O4 | 2757194-03-7 | Details |
| Factor B-IN-2 | C25H32N2O4 | 2760669-72-3 | Details |
| CSF1R-IN-9 | C26H26N4O2 | 2765301-84-4 | Details |
| Tubulin polymerization-IN-19 | C25H25NO5 | 2340345-85-7 | Details |
| TRPC6-IN-2 | C19H17Cl2FN6 | 2308595-83-5 | Details |
| Influenza virus-IN-5 | C21H26ClN3O2S | 2581825-57-0 | Details |
| COX-2-IN-17 | C20H23ClN6O2 | 2411390-10-6 | Details |
| PPARδ agonist 8 | C25H29NO5 | 2697129-55-6 | Details |
| Anti-inflammatory agent 21 | C24H21FO6 | 2408836-40-6 | Details |
| HDAC8/BRPF1-IN-1 | C19H19N3O6S | 2484255-85-6 | Details |
| DNA-PK-IN-5 | C21H22N8O2 | 2719736-43-1 | Details |
| Cap-dependent endonuclease-IN-6 | C23H21N3O3S | 2489248-15-7 | Details |
| MMV688844 | C23H25ClN4O2 | 2650213-59-3 | Details |
| Product Total： Product Page： | ||||
| 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 | ||||